We are live on ! Find out more
LIMNW

Liminatus Pharma Warrants
LIMNW

24 hedge funds and large institutions have $95K invested in Liminatus Pharma Warrants in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.3% less ownership

Funds ownership: 34.12% → 31.82% (-2.3%)

8% less funds holding

Funds holding: 26 → 24 (-2)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

76% less capital invested

Capital invested by funds: $400K → $95K (-$305K)

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5

Holders
24
Holders Change
-2
Holders Change %
-7.69%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
5
Closed
3
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$8K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.41K
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.25K
3
UBS Group
UBS Group
Switzerland
+$396

Top Sellers

Rank Fund Capital Flow
1
Nomura Holdings
Nomura Holdings
Japan
-$11.7K
2
AWG
Alpha Wave Global
New York
-$10.7K
3
MC
Meteora Capital
Florida
-$2.22K
4
GS
GTS Securities
New York
-$30
5
CS
Clear Street
New York
-$20
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
1
Clear Street
New York
$28.2K -$20 -200 -0%
AC
2
Aristeia Capital
Connecticut
$12.2K – – –
LA
3
Linden Advisors
New York
$10.6K – – –
SCM
4
Saba Capital Management
New York
$8.94K – – –
HCM
5
Highbridge Capital Management
New York
$5.55K – – –
PAMP
6
Polar Asset Management Partners
Ontario, Canada
$4.69K – – –
MCM
7
Moore Capital Management
New York
$4.38K – – –
MI
8
MMCAP International
Cayman Islands
$3.91K – – –
D.E. Shaw & Co
9
D.E. Shaw & Co
New York
$2.92K – – –
WAM
10
Wolverine Asset Management
Illinois
$2.2K -$7 -68 -0.1%
BOCH
11
Blue Owl Capital Holdings
New York
$2K – – –
PC
12
Periscope Capital
Ontario, Canada
$1.73K – – –
Toronto Dominion Bank
13
Toronto Dominion Bank
Ontario, Canada
$1.23K – – –
LP
14
LMR Partners
United Kingdom
$1.05K – – –
GS
15
GTS Securities
New York
$1.04K -$30 -300 -1%
ACA
16
Arena Capital Advisors
California
$1.02K – – –
Jane Street
17
Jane Street
New York
$850 -$15 -153 -0.6%
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
$837 +$2.41K +23,906 New
LIA
19
Limestone Investment Advisors
New York
$790 – – –
Point72 Asset Management
20
Point72 Asset Management
Connecticut
$434 +$1.25K +12,400 New
DCM
21
Dupont Capital Management
Delaware
$219 – – –
UBS Group
22
UBS Group
Switzerland
$147 +$396 +3,922 +1,352%
HIM
23
HGC Investment Management
Ontario, Canada
$44 – – –
Bank of America
24
Bank of America
North Carolina
$4 -$10 -100 -50%
Nomura Holdings
25
Nomura Holdings
Japan
– -$11.7K -97,325 Closed
1
2

LIMNW Hedge Fund Activity: Q4 2025 in Review

24 of the 8,232 institutional investors tracked by Wall St. Rank reported a position in Liminatus Pharma Warrants (LIMNW) for Q4 2025, worth a combined $95K — down 76% from $400K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of LIMNW and 2 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 1 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $2.41K. The largest seller was Nomura Holdings, exiting entirely with an estimated $11.7K sold.

  • 24 institutional investors held Liminatus Pharma Warrants (LIMNW) as of Q4 2025, down from 26 in Q3 2025.
  • Funds reported $95K of Liminatus Pharma Warrants stock for Q4 2025, down 76% quarter-over-quarter.
  • 2 funds opened new Liminatus Pharma Warrants positions in Q4 2025 and 3 closed out, a net change of -1 holder.
  • The largest Liminatus Pharma Warrants buyer in Q4 2025 was Susquehanna International Group, an estimated $2.41K added.
  • The largest Liminatus Pharma Warrants seller in Q4 2025 was Nomura Holdings, an estimated $11.7K sold.

Based on aggregated 13F filings for Q4 2025.